stoxline Quote Chart Rank Option Currency Glossary
  
The Oncology Institute, Inc. (TOI)
0.5352  0.015 (2.84%)    07-19 15:13
Open: 0.511
High: 0.5595
Volume: 32,480
  
Pre. Close: 0.52
Low: 0.511
Market Cap: 40(M)
Technical analysis
2024-07-19 2:54:50 PM
Short term     
Mid term     
Targets 6-month :  0.68 1-year :  0.79
Resists First :  0.58 Second :  0.68
Pivot price 0.48
Supports First :  0.47 Second :  0.4
MAs MA(5) :  0.51 MA(20) :  0.47
MA(100) :  0.98 MA(250) :  1.36
MACD MACD :  -0.1 Signal :  -0.1
%K %D K(14,3) :  74 D(3) :  71.1
RSI RSI(14): 55.6
52-week High :  2.65 Low :  0.4
Price, MAs and Bollinger Bands

Price has closed above its short-term moving average. Short-term moving average is currently above mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is BULLISH in short-term; and NEUTRAL in mid-long term.
[ TOI ] has closed below upper band by 5.3%. Bollinger Bands are 70.6% narrower than normal. The narrow width of the bands suggests low volatility as compared to its normal range. The bands have been in this narrow range for 28 bars. This is a sign that the market may be about to initiate a new trend.

Stock Price Prediction
If tomorrow: Open lower Open higher
High: 0.59 - 0.59 0.59 - 0.59
Low: 0.5 - 0.5 0.5 - 0.5
Close: 0.52 - 0.52 0.52 - 0.52
Company Description

The Oncology Institute, Inc., an oncology company, provides medical oncology services in the United States. Its services include physician services, in-house infusion and dispensary, clinical trial services, radiation, outpatient stem cell transplants and transfusions programs, and patient support. The company also offers and manages clinical trial services, such as managing clinical trials, palliative care programs, and stem cell transplants services. It serves adult and senior cancer patients. The company operates 67 clinic locations. The Oncology Institute, Inc. was founded in 2007 and is based in Cerritos, California.

Headline News

Fri, 19 Jul 2024
A Piece Of The Puzzle Missing From The Oncology Institute, Inc.'s (NASDAQ:TOI) 28% Share Price Climb - Simply Wall St

Mon, 15 Jul 2024
The Oncology Institute, Inc. (NASDAQ:TOI) Short Interest Up 29.8% in June - Defense World

Tue, 14 May 2024
The Oncology Institute Reports First Quarter 2024 Financial Results and Reaffirms Full Year 2024 Guidance - Yahoo Finance

Sun, 05 May 2024
The Oncology Institute, Inc. (NASDAQ:TOI) Stock's 29% Dive Might Signal An Opportunity But It Requires Some Scrutiny - Simply Wall St

Tue, 23 Apr 2024
The Oncology Institute Announces First Quarter 2024 Earnings Release Date and Conference Call - StockTitan

Mon, 01 Apr 2024
The Oncology Institute, Inc. (NASDAQ:TOI) Q4 2023 Earnings Call Transcript - Yahoo Finance

Financial Analysis
Price to Book Value:
P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.
Outperform
Price to Earnings:
PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).
Outperform
Discounted cash flow:
DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.
Neutral
Return on Assets:
ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.
Neutral
Return on Equity:
ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.
Underperform
Debt to Equity:
evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.
Outperform
Stock Basics & Statistics
Exchange:
NASDAQ
Sector:
Healthcare
Industry:
Medical - Care Facilities
Shares Out 74 (M)
Shares Float 36 (M)
Held by Insiders 19.8 (%)
Held by Institutions 55.2 (%)
Shares Short 233 (K)
Shares Short P.Month 218 (K)
Stock Financials
EPS -0.82
EPS Est Next Qtrly 0
EPS Est This Year 0
EPS Est Next Year 0
Book Value (p.s.) 0.56
Profit Margin -21.3 %
Operating Margin -19 %
Return on Assets (ttm) -17.7 %
Return on Equity (ttm) -104.5 %
Qtrly Rev. Growth 24.2 %
Gross Profit (p.s.) 0
Sales Per Share 4.6
EBITDA (p.s.) -0.76
Qtrly Earnings Growth 0 %
Operating Cash Flow -37 (M)
Levered Free Cash Flow -15 (M)
Stock Valuations
PE Ratio -0.67
PEG Ratio 0
Price to Book value 0.96
Price to Sales 0.11
Price to Cash Flow -1.1
Stock Dividends
Dividend 0
Forward Dividend 0
Dividend Yield 0%
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.

StockChart iOS

StoxlineLite iOS

StoxlineLite iOS

OptionCalc iOS

StockChart Android

StoxlineLite Android

StoxlinePro Android

OptionCalc Android